CARMAN/BIO CARMAN
Laufzeit: 01.01.2023 - 31.12.2030
imported
Kurzfassung
CAR T cell treatment for untreated high risk MANtle Cell Lymphoma
Laufzeit: 01.01.2023 - 31.12.2030
CAR T cell treatment for untreated high risk MANtle Cell Lymphoma